.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021106

« Back to Dashboard
NDA 021106 describes SOMAVERT, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the SOMAVERT profile page.

The generic ingredient in SOMAVERT is pegvisomant. One supplier is listed for this compound. Additional details are available on the pegvisomant profile page.

Summary for NDA: 021106

Tradename:
SOMAVERT
Applicant:
Pharmacia And Upjohn
Ingredient:
pegvisomant
Patents:2
Therapeutic Class:Hormonal Agents, Suppressant (Pituitary)

Suppliers and Packaging for NDA: 021106

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SOMAVERT
pegvisomant
INJECTABLE;SUBCUTANEOUS 021106 NDA Pharmacia and Upjohn Company LLC 0009-5176 0009-5176-01 1 KIT in 1 PACKAGE (0009-5176-01) * 1 mL in 1 VIAL, SINGLE-DOSE (0009-5175-01) * 1 mL in 1 VIAL, SINGLE-DOSE
SOMAVERT
pegvisomant
INJECTABLE;SUBCUTANEOUS 021106 NDA Pharmacia and Upjohn Company LLC 0009-5176 0009-5176-02 1 KIT in 1 PACKAGE (0009-5176-02) * 1 mL in 1 VIAL, SINGLE-DOSE (0009-5175-01) * 1 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;SUBCUTANEOUSStrength10MG/VIAL
Approval Date:Mar 25, 2003TE:RLD:Yes
Patent:5,849,535Patent Expiration:Mar 25, 2017Product Flag?Substance Flag?YDelist Request?
Patent:6,057,292Patent Expiration:Sep 21, 2015Product Flag?Substance Flag?Delist Request?
Patented Use:ACROMEGALY IN PATIENTS W/INADEQUATE RESPONSE TO SURGERY AND/OR RADIATION THERAPY AND/OR MEDICAL THERAPIES, OR FOR WHOM THESE THERAPIES ARE NOT APPROPRIATE

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;SUBCUTANEOUSStrength15MG/VIAL
Approval Date:Mar 25, 2003TE:RLD:Yes
Patent:5,849,535Patent Expiration:Mar 25, 2017Product Flag?Substance Flag?YDelist Request?

Expired Orange Book Patents for NDA: 021106

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
SOMAVERT
pegvisomant
INJECTABLE;SUBCUTANEOUS021106-003Mar 25, 20035,681,809► subscribe
Pharmacia And Upjohn
SOMAVERT
pegvisomant
INJECTABLE;SUBCUTANEOUS021106-002Mar 25, 20035,350,836► subscribe
Pharmacia And Upjohn
SOMAVERT
pegvisomant
INJECTABLE;SUBCUTANEOUS021106-003Mar 25, 20035,958,879► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc